Financhill
Back

Aptevo Therapeutics Quote, Financials, Valuation and Earnings

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Sell
40

APVO
Aptevo Therapeutics

Last Price:
0.27
Seasonality Move:
-10.33%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Aptevo Therapeutics Price Quote

$0.27
0.00 (-12.62%)
(Updated: November 9, 2024 at 5:12 AM ET)

Aptevo Therapeutics Key Stats

Sell
40
Aptevo Therapeutics (APVO) is a Sell

Day range:
$0.26 - $0.33
52-week range:
$0.14 - $10.80
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.03
P/B ratio:
0.57%

Volume:
2.8M
Avg. volume:
11.8M
1-year change:
-97.42%
Market cap:
$2.6M
Revenue:
$0
EPS:
$-46.96

How Much Does Aptevo Therapeutics Make?

Data Unavailable

Is Aptevo Therapeutics Growing As A Company?

Data Unavailable

Aptevo Therapeutics Stock Price Performance

What Is Aptevo Therapeutics 52-Week High & Low?

Aptevo Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Aptevo Therapeutics?

Is Aptevo Therapeutics Cash Flow Positive?

  • What Is APVO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$24.3M
  • What Is Aptevo Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $11.4M
  • What Is Aptevo Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Aptevo Therapeutics Return On Invested Capital

Data Unavailable

Aptevo Therapeutics Earnings Date & Stock Price

Aptevo Therapeutics Competitors

Aptevo Therapeutics Dividend Yield

Aptevo Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 15.79%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 8.00
Upside from Last Price: 2845.51%

Major Shareholders

  • How many APVO shares are owned by institutional investors?
    2M APVO shares are owned by institutional investors
  • How many APVO shares are owned by insiders?
    0 APVO shares are owned by insiders